Drug of choice for a 14 year old child with depression?

NIMHANS Nursing Officer - 2019

Edition 3

Easy

Appeared in: NIMHANS Nursing Officer - 2019

Explanation

Fluoxetine is a Selective Serotonin Reuptake Inhibitor (SSRI), which is the first-line drug class for treating depression in children and adolescents.
It is specifically approved by the U.S. Food and Drug Administration (FDA) for the treatment of Major Depressive Disorder (MDD) in patients aged 8 to 17 years.
Compared to other antidepressant classes like TCAs, SSRIs have a more favorable side-effect profile and are significantly safer in case of an overdose.

Option B: Amitriptyline is a Tricyclic Antidepressant (TCA) and is not a first-line agent for pediatric depression due to its significant side effect profile (anticholinergic, cardiotoxic) and high risk of lethality in overdose.
Option C: Imipramine is also a Tricyclic Antidepressant (TCA) with a similar risk profile to amitriptyline. It is not recommended as a first-line treatment for depression in adolescents.
Option D: Alprazolam is a benzodiazepine, an anxiolytic medication used for anxiety, not a primary treatment for depression. It acts on GABA receptors, not the serotonin system, and carries a high risk of dependence.

Clinical Relevance

Nursing practice connection: Use the key finding related to Pharmacological treatment of depression in adolescents to guide bedside assessment, documentation, and the next nursing action.
The most critical nursing responsibility when administering antidepressants to adolescents is monitoring for increased suicidal ideation. The FDA has issued a 'black box' warning for this risk, especially during the first few months of therapy.
Nurses must educate the patient and family that the full therapeutic effects of fluoxetine may take 4-6 weeks to manifest, and adherence to the regimen is crucial even if immediate improvement is not felt.
What if the 14-year-old patient also had a seizure disorder? Bupropion would be contraindicated, and caution would be needed with TCAs as they can lower the seizure threshold. Fluoxetine would likely remain a safe and appropriate choice.

How to Approach the Question

First, identify the key elements of the question: the patient's age (14 years old), the diagnosis (depression), and the task (find the 'drug of choice').
Recognize that 'drug of choice' implies the first-line, safest, and most effective recommended treatment.
Categorize the options by drug class: Fluoxetine (SSRI), Amitriptyline/Imipramine (TCAs), and Alprazolam (Benzodiazepine).
Recall or deduce the primary use for each drug class. SSRIs and TCAs are antidepressants, while benzodiazepines are anxiolytics.
Compare the suitability of SSRIs and TCAs for pediatric patients. Remember that SSRIs are preferred due to a better safety profile and lower overdose risk.
Based on this, select Fluoxetine as the only SSRI option and the established first-line treatment for this patient population.

Concept Tested & Keywords

Concept Tested: Pharmacological treatment of depression in adolescents.
Stem keywords: Drug of choice, 14 year old child, depression
Lead-in keywords: Drug of choice
Clinical cues: Patient age of 14 years is critical, indicating pediatric/adolescent pharmacology guidelines apply.

Qyxbh9OH8My7WRqhuvnSOY

E6 Nelson Textbook of Pediatrics(2024) — Volume 1 p. 270-272

E6 Kaplan Sadock's Synopsis of Psychiatry-2022 (pp 1-3768 of 3768) p. 631-633